Enterprise Therapeutics Receives Funding from Cystic Fibrosis Trust

News   Apr 05, 2017 | Original story from Enterprise Therapeutics

 
Enterprise Therapeutics Receives Funding from Cystic Fibrosis Trust
 
 
 
 

RELATED ARTICLES

Freedom of Information Request Reveals Benefits of Blocked MS Drug

News

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

READ MORE

Blood-vessel-on-a-Chip Models Vascular Barrier Function

News

A newly developed human blood-vessel-on-a-chip models the vascular barrier and reveals a new cell migration-based mechanism for fibrotic diseases.

READ MORE

A New Method of 3D Printing Living Tissues

News

Scientists at the University of Oxford have developed a new method to 3D-print laboratory-grown cells to form living structures.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE